|
Getting your Trinity Audio player ready... |
Barbados: Barbados reported a total of 195 new cases of the COVID-19 mutant, comprising 94 males and 101 females. So far, the island has reported a total of 9,205 confirmed cases of the deadliest mutant, according to the health ministry’s report till 3 October 2021.
As per to the report, there are 996 individuals who are in isolation till 3 October 2021, while one individual lost life to the COVID-19 mutant.
Two deaths that were reported in the island country were of a 64-year-old St. Lucian man who died after spending 7 days in primary isolation at the Harrison Point facility. The other death is a 70-year-old Barbadian woman who died in primary isolation at Harrison Point, where she was for 9 days.
With these additional deaths, the toll of people who scummed to contagious COVID-19 outbreak has risen to 81.
Since the pandemic started in the island country, that is – in March 2020, Barbados has reported a total of 9,205 cases (4,498 males and 4,707 females). The public health laboratory has performed 326,487 tests.
Barbados COVID-19 situation reports further states that so far, a total of 138,666 individuals have received their first jab of the COVID-19 vaccine, while a total of 107,470 individuals that is 39.7 per cent of the population, has received their second shot of the vaccine and are now fully vaccinated against the deadly virus.
Out of the 195 new cases registered, 44 out of them are under 18 years, and 151 individuals are 18 years older or above.
If the citizens have any queries regarding the COVID-19 update or vaccination, they can contact at the following numbers – 536-4500 or 536-3865.
Prime Minister – Mia Amor Mottley, along with the health ministry, is urging the citizens to abide by the COVID-19 protocols/measures such as – wearing masks, sanitizing frequently and maintaining a social distance.
She also urged the Barbadians to take their jabs of the vaccine as soon as possible so as to decrease the chances of transmission and assist the nation in achieving its target of herd immunity.
